Tranexamic acid(TXA) is an antifibrinolytic agent to reduce blood loss in cardiac surgery.
Previous seven RCTs comparing effects of TXA in pediatric cardiac surgery showed conflict
results. The reason why they showed mixed results would be the imbalance of patients
population with regard to presence of cyanosis. TXA would reduce blood loss in pediatric
cardiac surgery with well balanced patients population.